EDIT vs ROP
Editas Medicine Inc (EDIT) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
EDIT currently screens at market cap $375.2M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the EDIT and ROP stock pages for the full models.
Not investment advice.